New York (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von Guggenheim Securities:
Die Analysten von Guggenheim Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292,…
4 March 2024
Two datopotamab deruxtecan applications validated in the EU for
patients with advanced nonsquamous non-small cell lung
cancer or HR-positive, HER2-negative…